These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Cardiorespiratory involvement in progressive systemic sclerosis]. García de Castro J; Ledro D; Rubio E; Garrido M Rev Clin Esp; 1984 Jul 15-31; 174(1-2):45-7. PubMed ID: 6515063 [No Abstract] [Full Text] [Related]
9. [Importance of the changes in pulmonary diffusion capacity in the evaluation of the functional respiratory damage in scleroderma]. Catenacci G; Carosi L Folia Med (Napoli); 1967 Dec; 50(12):890-8. PubMed ID: 5617897 [No Abstract] [Full Text] [Related]
13. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Steen VD; Medsger TA Arthritis Rheum; 2000 Nov; 43(11):2437-44. PubMed ID: 11083266 [TBL] [Abstract][Full Text] [Related]
14. Retrospective study of clinical and laboratory features in Japanese scleroderma patients with cardiac involvement. Jinnin M; Ihn H; Asano Y; Yamane K; Yazawa N; Tamaki K J Dermatol Sci; 2009 Jul; 55(1):70-2. PubMed ID: 19375289 [No Abstract] [Full Text] [Related]
15. [Visceral scleroderma]. Chomette G; Tranbaloc P; Beaufils H; Auriol M Ann Med Interne (Paris); 1984; 135(8):606-10. PubMed ID: 6529056 [TBL] [Abstract][Full Text] [Related]
16. [Scleroderma and its visceral complications]. Huriez C Maroc Med; 1972 Jun; 52(558):331-44. PubMed ID: 4636029 [No Abstract] [Full Text] [Related]
17. [Electrocardiographic and echocardiographic manifestations in scleroderma. An analysis of the findings in 31 patients]. Mendoza G; Berensztein CS; Martínez Martínez JA; Torino AF; Suárez LD Rev Clin Esp; 1986 Oct; 179(5):248-51. PubMed ID: 3786861 [No Abstract] [Full Text] [Related]
18. [Visceral manifestations of diffuse scleroderma]. Suţeanu S; Moise A; Stoicescu M Med Interne; 1988; 26(2):125-38. PubMed ID: 3291079 [No Abstract] [Full Text] [Related]